Imbimbo, B P <br/><br/>
Two-year treatment of Alzheimer's disease with eptastigmine. The Eptastigmine Study Group.  [electronic resource] 

 -  Dementia and geriatric cognitive disorders   
 - 139-47 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1420-8008 
<br/><br/><label>Standard No.: </label>10.1159/000017114  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Activities of Daily Living<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Alzheimer Disease--drug therapy<br/>Cholinesterase Inhibitors--adverse effects<br/>Cognition<br/>Disease Progression<br/>Double-Blind Method<br/>Drug Monitoring<br/>Electrocardiography<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Physostigmine--adverse effects